Table 4 of Yaylacioglu Tuncay, Mol Vis 2016; 22:1267-1279.


Table 4. Variations of CHST6 identified in Turkish MCD patients.

Nucleotide change Amino acid change Variation type Immunotype Patient no Polyphen SIFT HGMD No
c.738 C>G p.C246W missense I 1(1:homozygote) 1
(probably damaging) 0
(not tolerated) CM065078
c.1 A>T p. M1L First codon loss II 1(2:heterozygote) MD MD CM0650699
c.894_895 insG p. Q298fs frameshift I 5(4,7,11,14,18: homozygote) MD MD Novel
c.610 C>T p. P204S missense I 3(3: homozygote; 6: compound heterozygote 1
(probably damaging) 0,01
(not tolerated) Novel
c.462_463 del GC p. R155Afs frameshift I 1(6:compound heterozgote) MD MD Novel
c.526 G>A p. V176M missense I,II 2(8,15:homozygote; 9:compound heterozygote) 1
(probably damaging) 0
(not tolerated) Novel
c. 631 C>T p. R211W missense I 3(10,12,17: homozygote) 1
(probably damaging) 0
(not tolerated) CM002586
c.164 T>C p. F55S missense I 1(9:compund heterozygote) 0,968
(probably damaging) 0
(not tolerated) Novel